Earlier the better: Convalescent plasma

Aaron A.R. Tobian, Beth H. Shaz

Research output: Contribution to journalReview articlepeer-review

Abstract

In the current issue of Blood, Xia et al evaluate the use of convalescent plasma for the treatment of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19).1,2 SARS-CoV-2 has spurred a global crisis. To date, there are limited treatment options for COVID-19 and no proven prophylactic therapies for those who have been exposed to SARS-CoV-2.

Original languageEnglish (US)
Pages (from-to)652-654
Number of pages3
JournalBlood
Volume136
Issue number6
DOIs
StatePublished - Aug 2020

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Earlier the better: Convalescent plasma'. Together they form a unique fingerprint.

Cite this